Daxor Net Profit Margin 2012-2011 | DXR
Daxor net profit margin from 2012 to 2011. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Daxor Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2011-12-31 | $0.00B | $-0.01B | 0.00% |
| 2011-09-30 | $0.00B | $0.00B | 0.00% |
| 2011-06-30 | $0.00B | $0.00B | 0.00% |
| 2011-03-31 | $0.00B | $0.00B | 0.00% |
| 2010-12-31 | $0.00B | $0.01B | 0.00% |
| 2010-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| 2010-03-31 | $0.00B | $0.01B | 0.00% |
| 2009-12-31 | $0.00B | $0.01B | 0.00% |
| 2009-09-30 | $0.00B | $0.01B | 0.00% |
| 2009-06-30 | $0.00B | $0.01B | 0.00% |
| 2009-03-31 | $0.00B | $0.01B | 600.00% |
| 2008-12-31 | $0.00B | $0.02B | 1500.00% |
| 2008-09-30 | $0.00B | $0.02B | 1800.00% |
| 2008-06-30 | $0.00B | $0.01B | 1400.00% |
| 2008-03-31 | $0.00B | $0.01B | 1400.00% |
| 2007-12-31 | $0.00B | $0.01B | 500.00% |
| 2007-09-30 | $0.00B | $0.01B | 350.00% |
| 2007-06-30 | $0.00B | $0.00B | 200.00% |
| 2007-03-31 | $0.00B | $0.00B | 200.00% |
| 2006-12-31 | $0.00B | $0.00B | 0.00% |
| 2006-09-30 | $0.00B | $0.00B | 0.00% |
| 2006-06-30 | $0.00B | 0 | 0.00% |
| 2006-03-31 | $0.00B | $0.00B | 0.00% |
| 2005-12-31 | $0.00B | $0.00B | 0.00% |
| 2005-09-30 | $0.00B | 0 | 0.00% |
| 2005-06-30 | $0.00B | $0.00B | 0.00% |
| 2005-03-31 | $0.00B | 0 | 0.00% |
| 2004-12-31 | $0.00B | 0 | 0.00% |
| 2004-09-30 | $0.00B | 0 | 0.00% |
| 2004-06-30 | $0.00B | 0 | 0.00% |
| 2004-03-31 | $0.00B | 0 | 0.00% |
| 2003-12-31 | $0.00B | 0 | 0.00% |
| 2003-09-30 | $0.00B | 0 | 0.00% |
| 2003-06-30 | $0.00B | 0 | 0.00% |
| 2003-03-31 | $0.00B | 0 | 0.00% |
| 2002-12-31 | $0.00B | 0 | 0.00% |
| 2002-09-30 | $0.00B | 0 | 0.00% |
| 2002-06-30 | $0.00B | 0 | 0.00% |
| 2002-03-31 | $0.00B | 0 | 0.00% |
| 2001-12-31 | $0.00B | 0 | 0.00% |
| 2001-09-30 | $0.00B | 0 | 0.00% |
| 2001-06-30 | $0.00B | 0 | 0.00% |
| 2001-03-31 | $0.00B | 0 | 0.00% |
| 2000-12-31 | $0.00B | 0 | 0.00% |
| 2000-09-30 | $0.00B | 0 | 0.00% |
| 2000-06-30 | $0.00B | 0 | 0.00% |
| 2000-03-31 | $0.00B | 0 | 0.00% |
| 1999-12-31 | $0.00B | 0 | 0.00% |
| 1999-09-30 | $0.00B | 0 | 0.00% |
| 1999-06-30 | $0.00B | 0 | 0.00% |
| 1999-03-31 | $0.74B | 0 | 0.00% |
| 1998-12-31 | $0.74B | 0 | 0.00% |
| 1998-06-30 | $0.74B | 0 | 0.00% |
| 1998-03-31 | $0.00B | 0 | 0.00% |
| 1996-12-31 | $0.00B | 0 | 0.00% |
| 1996-09-30 | $0.00B | $0.00B | 50.00% |
| 1996-06-30 | $0.00B | 0 | 0.00% |
| 1996-03-31 | $0.00B | 0 | 0.00% |
| 1995-12-31 | $0.00B | $0.00B | 50.00% |
| 1995-06-30 | $0.00B | $0.00B | 200.00% |
| 1995-03-31 | $0.00B | $0.00B | 300.00% |
| 1994-06-30 | $0.00B | $0.00B | 0.00% |
| 1994-03-31 | $0.00B | $0.00B | 400.00% |
| 1993-12-31 | $0.00B | $0.00B | 300.00% |
| 1993-09-30 | $0.00B | $0.00B | 200.00% |
| 1993-06-30 | $0.00B | $0.00B | 100.00% |
| 1993-03-31 | $0.00B | $0.00B | 300.00% |
| 1992-12-31 | $0.00B | $0.00B | 200.00% |
| 1992-09-30 | $0.00B | 0 | 0.00% |
| 1992-06-30 | $0.00B | 0 | 0.00% |
| 1992-03-31 | $0.00B | $0.00B | -200.00% |
| 1991-12-31 | $0.00B | $0.00B | -100.00% |
| 1991-09-30 | $0.00B | $0.00B | 150.00% |
| 1991-06-30 | $0.00B | $0.00B | 100.00% |
| 1991-03-31 | $0.00B | $0.00B | 133.33% |
| 1990-12-31 | $0.00B | $0.00B | 133.33% |
| 1990-09-30 | $0.00B | $0.00B | 25.00% |
| 1990-06-30 | $0.00B | 0 | 0.00% |
| 1990-03-31 | $0.00B | 0 | 0.00% |
| 1989-12-31 | $0.00B | 0 | 0.00% |
| 1989-09-30 | $0.00B | $0.00B | 66.67% |
| 1989-06-30 | $0.00B | $0.00B | 50.00% |
| 1989-03-31 | $0.00B | $0.00B | 50.00% |
| 1988-12-31 | $0.00B | $0.00B | 75.00% |
| 1988-09-30 | $0.00B | $0.00B | 33.33% |
| 1988-06-30 | $0.00B | $0.00B | 33.33% |
| 1988-03-31 | $0.00B | 0 | 0.00% |
| 1987-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.065B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |